William K. Heiden - 19 Aug 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
19 Aug 2025
Net transactions value
+$150,515
Form type
4
Filing time
21 Aug 2025, 16:19:48 UTC
Previous filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HEIDEN WILLIAM K Director 9704 MEDICAL CENTER DRIVE, ROCKVILLE /s/ Beth A. Smith, Attorney-in-fact 21 Aug 2025 0001214939

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Purchase $76,760 +50,500 +459% $1.52 61,500 19 Aug 2025 Direct F1
transaction MGNX Common Stock Purchase $73,755 +49,500 +80% $1.49 111,000 20 Aug 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.48 to $1.59. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 This transaction was executed in multiple trades at prices ranging from $1.46 to $1.50. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.